高级检索
袁国平, 李明珠, 于科, 褚国方. 乙肝疫苗联合免疫球蛋白阻断母婴传播效果[J]. 中国公共卫生, 2009, 25(12): 1479-1480. DOI: 10.11847/zgggws2009-25-12-36
引用本文: 袁国平, 李明珠, 于科, 褚国方. 乙肝疫苗联合免疫球蛋白阻断母婴传播效果[J]. 中国公共卫生, 2009, 25(12): 1479-1480. DOI: 10.11847/zgggws2009-25-12-36
YUAN Guo-ping, LI Ming-zhu, YU Ke, . Effect of recombinant hepatitis B vaccine combined with hepatitis B immunglobulin(HBIG) in interruption of vertical transmission of HBV[J]. Chinese Journal of Public Health, 2009, 25(12): 1479-1480. DOI: 10.11847/zgggws2009-25-12-36
Citation: YUAN Guo-ping, LI Ming-zhu, YU Ke, . Effect of recombinant hepatitis B vaccine combined with hepatitis B immunglobulin(HBIG) in interruption of vertical transmission of HBV[J]. Chinese Journal of Public Health, 2009, 25(12): 1479-1480. DOI: 10.11847/zgggws2009-25-12-36

乙肝疫苗联合免疫球蛋白阻断母婴传播效果

Effect of recombinant hepatitis B vaccine combined with hepatitis B immunglobulin(HBIG) in interruption of vertical transmission of HBV

  • 摘要: 目的 观察比较乙肝疫苗(Hep-B)联合乙肝免疫球蛋白(HBIG)阻断乙肝母婴传播的效果,为制订阻断乙肝母婴传播策略提供依据.方法 选择上海市宝山区6家综合性医院妇产科产前检查中检出的HBsAg阳性和HBsAg/HBeAg双阳性的本区户籍产妇85人,分为3组.其中观察Ⅰ组(22人)新生儿出生24 h内和15 d各接种1针HBIG;观察Ⅱ组孕产妇(37人)于28,32,36孕周各接种1针HBIG,婴儿出生24 h内和15 d各接种1针HBIG;对照组(26人)不接种HBIG.HBIG均为200 U/针.3个组的新生儿均按正常免疫程序于0,1,6个月时各接种1针10μg重组(酵母)Hep-B疫苗.1年后采集幼儿静脉血,采用ELISA法检测HBsAg和抗-HBs.结果 观察Ⅰ组、Ⅱ组和对照组婴儿出生后12个月时,HBsAg阳性率分别为17.24%,2.70%和23.04%,抗-HBs阳性率分别为86.36%,97.30%和76.92%;观察Ⅱ组母婴传播阻断率和免疫保护率均高于观察Ⅰ组和对照组,差异有统计学意义(P<0.05).结论 HBIG与重组(酵母)Hep-B疫苗联合应用免疫效果好,安全可行,且观察Ⅱ组的效果优于观察Ⅰ组.

     

    Abstract: Objective To observe and compare the effect of recombinant hepatitis Bvaccine combined with HBIG in interrupting the vertical transmission of HBV,and to provide foundation for making countermeasure of interrupting vertical transmission of HBV.Methods Eighty-five local women taking part in prenatal examination at the regional comprehensive hospitals and with positive HBsA gor HBsAg/HbeAg were divided in to three groups.For groupⅠ(n=22)the new borns were vaccinated with HBIG two times with in 24 hours and 15 days later(200 IU/needle).For groupⅡ(n=37)the pregnant women were vaccinated with HBIG three times in 28th,32rd,36th pregnancy week(200 IU/needle),and the new-borns were vaccinated with HBIG two times with in 24 hours and 15 dayslater(200 IU/needle).The control group(n=26)the pregnant women were not vaccinated.All the new borns of the three groups were vaccinated with 10μg recom binant hepatitis Bvaccine in the regular immunity procedure(0,1,6th months).One year later the blood samples of the infants were collected and detected with EL ISA for HBsAg and anti-HBs.Results The positive rates of HBsAg in the infants of one year old in groupⅠ,groupⅡ and control group were 17.24%,2.70% and 23.04% and the positive rates of anti-HBs were 86.36%,97.30% and 76.92%,respectively.The interruptive and immunity protection rates of vertical transmission in groupⅡ was beter than in groupⅠand control group with significant difference(P<0.05).Conclusion The recombinant hepatitis Bvaccine combined with HBIG in interruption of vertical transmission of HBV is good,safe and applicable.

     

/

返回文章
返回